Skip to main content

Table 2 Correlated miRNA - gene expression pairs in ESCCa

From: Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis

No.

miRNA

miRNA fold changeb

No. correlated genes

Correlated gene

Gene fold changec

Rho

P-value

1

has-miR-155

1.73

3

PSMB9

2.50

0.57

<10E-12

    

BTN3A3 /// BTN3A2

1.70

0.55

6.80E-10

    

UBE2L6

1.90

0.54

2.20E-09

2

hsa-miR-133a

0.19

2

SLC2A1

2.40

−0.52

4.50E-09

    

SLC6A8

1.90

−0.52

7.10E-09

3

hsa-miR-135a*

0.89

1

BC37295_3

0.83

0.53

2.80E-09

4

hsa-miR-145

0.29

1

SMC4

1.20

−0.54

1.50E-09

5

hsa-miR-149

0.4

6

IFI30

2.40

−0.52

4.80E-09

    

PSME2

1.70

−0.52

6.30E-09

    

GZMA

1.50

− 0.52

5.40E-09

    

PSMB8

1.80

− 0.54

6.00E-10

    

TRA@ /// TRD@

1.10

− 0.54

1.30E-09

    

PSMB9

2.50

−0.56

3.70E-12

6

hsa-miR-150

0.49

5

CCR7

1.10

0.57

0

    

IGHM

0.94

0.54

1.10E-09

    

SELL

1.30

0.52

4.70E-09

    

CCL19

0.81

0.52

6.70E-09

    

MS4A1

1.10

0.52

5.80E-09

7

hsa-miR-200b

1.11

7

GPR116

1.10

−0.52

7.40E-09

    

DMD

0.58

−0.53

4.90E-09

    

IL33

0.61

−0.53

2.60E-09

    

RFTN1

1.20

−0.53

4.30E-09

    

PPARGC1A

0.71

−0.53

4.70E-09

    

GPM6A

0.68

−0.54

1.50E-09

    

GEM

0.80

−0.56

1.40E-10

8

hsa-miR-203

0.31

146

DSG3

0.45

0.63

<10E-12

    

CST6

0.35

0.62

<10E-12

    

IL1RN

0.16

0.62

<10E-12

    

MAP3K9

0.50

0.62

<10E-12

    

GLTP

0.28

0.62

<10E-12

    

AIM1L /// FLJ38020

0.29

0.62

<10E-12

    

PPL

0.17

0.61

<10E-12

    

SERPINB13

0.19

0.61

<10E-12

    

FBXO34

0.57

0.61

<10E-12

    

EVPL

0.29

0.60

<10E-12

    

SPRR1B

0.43

0.60

<10E-12

    

SERPINB13

0.22

0.60

<10E-12

    

SPRR1A

0.27

0.60

<10E-12

    

RAPGEFL1

0.54

0.60

<10E-12

    

ZNF750

0.29

0.60

<10E-12

    

(for full set of genes correlated with miR-203, see Supplementary TableS3)

9

hsa-miR-205

0.89

5

F12

1.10

0.57

<10E-12

    

STX6

1.10

0.54

1.30E-09

    

HSPA4

0.85

0.52

6.90E-09

    

MGC24039

0.97

−0.52

5.60E-09

    

PFAAP5

0.90

−0.53

3.50E-09

10

hsa-miR-214

1.17

3

CHAF1A

1.40

−0.52

4.70E-09

    

EZH2

2.10

−0.54

1.60E-09

    

TMPO

1.50

−0.54

8.50E-10

11

hsa-miR-224

1.56

1

F12

1.10

0.53

2.00E-09

12

hsa-miR-320

0.51

2

ACOX2

0.50

0.51

6.60E-09

    

EZH2

2.10

−0.54

4.40E-10

13

hsa-miR-375

0.02

2

IL1RN

0.16

0.59

9.90E-10

    

PSG3

0.62

0.58

1.40E-09

14

hsa-miR-574–3p

0.45

5

ADD1

0.72

0.53

2.30E-09

    

GAS7

0.52

0.52

7.00E-09

    

EZH2

2.10

−0.52

7.80E-09

    

TMPO

1.50

−0.52

5.60E-09

    

C13orf34

1.90

−0.52

4.80E-09

15

hsa-miR-650

0.98

15

LOC91316

1.50

0.64

<10E-12

    

POU2AF1

1.70

0.60

<10E-12

    

CTA-246H3.1

1.80

0.58

<10E-12

    

MGC29506

1.30

0.58

<10E-12

    

CD79A

1.00

0.55

2.50E-10

    

IGHA1 /// IGHG1 /// IGHG3 /// IGHM

1.20

0.55

5.90E-10

    

IL8

1.60

0.54

2.10E-09

    

IVD

1.60

0.54

1.20E-09

    

CXCL13

2.80

0.53

3.20E-09

    

IGL@

2.30

0.53

3.70E-09

    

IGKC /// NTN2L /// GJB6

2.40

0.53

2.60E-09

    

IGL@ /// IGLV4–3 /// IGLV3–25 /// IGLV2–14 /// IGLJ3

2.30

0.53

3.10E-09

    

IGL@ /// IGLV4–3 /// IGLV3–25 /// IGLV2–14

2.10

0.53

5.10E-09

    

HLA-C

2.00

0.52

6.30E-09

    

IGL@ /// IGLV3–25 /// IGLV2–14 /// IGLJ3

2.10

0.52

5.90E-09

16

hsa-miR-99b

0.79

1

SMC4

1.20

−0.52

4.40E-09

  1. aP-value threshold for multiple comparison adjustment = P < 8.40E-09 (0.05/5,947,959)
  2. bmedian miRNA fold change
  3. cmean gene expression fold change
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us